Coromandel International Ltd Directors Report

Dear Members,

The Board of Directors of your Company have pleasure in presenting the Sixty Third Annual Report on the operational and business performance of the Company together with the Audited Financial Statements (Standalone and Consolidated) for the financial year ended March 31, 2025.

1. Standalone Financial Highlights

Particulars	FY 2024-25	FY 2023-24
Revenue
From Operations	24,064.25	22,029.21
Other Income	363.71	279.09
Total Revenue	24,427.96	22,308.30
Profit
Profit before Interest, Depreciation and Taxation	3,019.58	2,679.93
Less: Interest	257.74	185.25
Less: Depreciation	276.71	222.20
Profit Before Exceptional items and Tax	2,485.13	2,272.48
Add: Exceptional items	100.17	-
Profit Before Tax	2,585.30	2,272.48
Less: Provision for Tax (including deferred tax)	644.40	553.23
Profit After Tax	1,940.90	1,719.25

Your Companys Revenue from Operations for the year was 24,064 Crores as against 22,029 Crores last year. The Profit before Interest, Depreciation, and Taxation stood at 3,020 from 2,680 Crores in the previous year registering an increase of 13% year-on-year (YoY). The Net Profit for the year was 1,941 Crores, an increase of 13% from 1,719 in the previous year. The EBITDA margin improved by 14 basis points to 11.04% and the PAT margin improved by 26 basis points to 8.07% over the previous reporting period. The Earnings Per Share (EPS) for the year stood at 65.96 per share compared to 58.42 per share for the previous year.

Transfer to Reserves

Your Company proposes to retain 1,940.90 Crores in the Statement of Profit and Loss, and not transfer it to the General Reserve.

2. Business Environment

Global & Indian economy

The global economy demonstrated resilience amid persistent challenges like rising trade tensions, geopolitical conflicts, high sovereign debt levels, and increased policy uncertainty in an election-heavy year and grew by 3.3% (IMF) in 2024. While advanced economies began to stabilize with slowing inflation and cautious monetary easing, emerging markets faced a slight deceleration amid tighter financial conditions and geopolitical uncertainties. In China, growth was mainly supported by external demand, while United States economy was boosted by private consumption.

Inflation globally declined from 6.8% in 2023 to 5.7%, though services inflation remained stubborn in many regions. The dollar appreciated sharply in the run-up to the US elections in November 2024, with markets expecting higher US growth and tighter monetary policy. Initial depreciation pressures were particularly pronounced for the currencies of emerging market and developing economies, but they have dissipated following the softening in 2025.

The escalation of trade tensions has generated extremely high levels of policy ambiguity and IMF forecasts the global economy to grow by 2.8% in 2025. Prices of fuel commodities are projected to decrease in 2025 by 7.9% as global supply conditions stabilize, energy production ramps up, and demand growth moderates.

World Economic Outlook, IMF (April 2025) in %	2023	2024 est	2025 proj
World	3.3	3.3	2.8
Advanced economies	1.7	1.8	1.4
US	2.9	2.8	1.8
EU	0.4	0.9	0.8
Emerging Market and Developing Economies	4.4	4.3	3.7
China	5.2	5.0	4.0
India	8.2	6.5	6.2

India continued its strong recovery post the pandemic, with a GDP growth rate of 6.5% (NSO, IMF), maintaining its position as one of the fastest-growing major economies. This growth is largely fuelled by resilient domestic demand, increased government spending on infrastructure projects, and a burgeoning digital economy. Indias consumption-driven economy benefits from robust private consumption, supported by improving wages, urbanization, and an expanding middle class. Inflation moderated during the year, driven by favourable agricultural output and a reduction in global fuel prices. RBI has embarked on monetary easing policy, reducing the report rates by 50 basis points upto April 2025.

Going forward, Indias outlook remains positive, with various agencies indicating 6.2-6.5% growth estimates in 2025. While the ongoing trade tensions and geopolitical uncertainties could pose risks to Indias export, it is also expected to benefit from shifting global supply chains.

Agriculture

India experienced a positive agriculture environment during 2024-25, aided by above normal monsoon (108% of long period average) and higher reservoir levels leading to higher crop sowings. The third advance estimate for 2024-25 placed foodgrains production at 354 million tons, marking an increase of 7% over the previous year. As per National Statistical Office (NSO), the Gross Value Added (GVA) in agriculture and allied activities for the fiscal year 2024–25 is projected to grow by 4.6% (2.7% last year), reflecting a positive turnaround in the sector.

Indias agricultural policy reforms in recent years have focused on enhancing productivity, ensuring food security, strengthening rural incomes, and building resilience against climate change. During the year, government focused on driving self-sufficiency in key crops such as pulses and oilseeds. It has extended the 100% procurement policy for pulses like tur, urad and masur under Price Support Scheme (PSS) for the next four years, up to 2028–29, to encourage domestic production and reduce import reliance. Similarly, the National Mission on Edible Oils – Oilseeds scheme was introduced, targeting self-reliance in edible oil production over a seven-year horizon.

The adoption of technology in Indian agriculture is gaining strong momentum, reflecting the sectors shift toward greater efficiency, resilience, and sustainability. There has been increased drone adoption in agriculture with increased usage for precision agriculture, such as crop health monitoring, pest management, and efficient spraying of fertilizers and agrochemicals. The Indian government has supported this adoption through various schemes like the Namo Drone Didi Scheme, Sub-Mission on Agricultural Mechanization (SMAM), which offers financial assistance for the purchase of drones and supporting women led Self help groups.

3. Performance review

In FY24-25, Coromandel achieved strong performance across its Nutrients and Crop Protection segments, supported by favourable factors such as a good monsoon, high reservoir levels, and increased crop sowing in target markets. The company saw record sales volumes in fertilizers, expanding its reach in North and Central India, and added over 100 retail stores. The crop protection business benefited from new product launches and strong demand for key molecules, while its nano products, specialty nutrients, organic and bio products drove integrated farm management practices. Financially, Coromandel reported impressive growth, with revenues rising by 9% and PAT improving by 13% over previous year.

Coromandel continued to invest in strengthening its plant infrastructure capabilities and is setting up granulation, phosphoric acid and sulphuric acid capacities at its fertiliser plant at Kakinada, besides investment in new product capacities in Crop protection.

The company maintained its focus on safety with a zero-incident culture, recording a Total Recordable Injury Rate (TRIR) of 0.3. It introduced 19 new products, including the innovative Urea SSP fertilizer and launched the patented product ‘Prachand in partnership with Japanese innovator.

Coromandel expanded its drone spraying operations through its ‘Gromor Drive initiative and retail channel, covering 2.2 lakh acres in seven states. This initiative is supported by Remote Pilot Training Organization (RPTO) trained pilots and is further expanded through value chain partnerships. The company also made strategic acquisitions, including a majority stake in NACL Industries, subject to regulatory clearance, and increased shareholding in Dhaksha Unmanned Systems and Baobab Mining and Chemicals Corporation SA.

The companys commitment to sustainability was evident in its ESG efforts, including waste heat utilization for energy, plastic management, usage of non-conventional desalinated water and farm-level interventions. It ranked in the top 7% of global chemical companies in the Dow Jones Sustainability Index (DJSI). Additionally, Coromandel continued its digital transformation, enhancing cybersecurity, and leveraging AI and ML for improved decision-making and efficiency.

Fertilizers

Coromandels fertilizer business delivered a record-breaking performance during the year, strengthening its position as Indias leading private sector phosphatic fertilizer player.

The company achieved its highest-ever production of 3.33 million tons while maintaining exceptional safety standards, with Visakhapatnam and Kakinada units receiving the British Safety Councils International Safety Award. Major projects, including capacity expansion for Phosphoric and Sulphuric acid plants at Kakinada, are progressing steadily. During the year, Coromandel commenced work on brownfield expansion by 0.75 million tons of its granulation capacity at Kakinada.

Coromandel strengthened its supply chain by diversifying sourcing and securing strategic partnerships. The company increased rock output from its mining project at Senegal through setting up of fixed processing plant and increased its stake in BMCC to 53.8%. Record sales volumes of close to 4 million tons were achieved in phosphatic fertilizers, as business expanded into North and Central India and registered a notable increase in consumption-based market share (18%). The Single Super Phosphate (SSP) business also grew, launching new value-added products and operating at higher capacities.

On the farmer engagement front, Coromandel expanded its network of Nutri Clinics and PMKSK centers, offering agronomic support and promoting balanced nutrition. The Gromor Drive drone spraying initiative scaled up, and business is aggressively expanding its drone fleet to improve coverage. Coromandel inaugurated a high-tech R&D Polyhouse for precision agriculture research and a Soil and Leaf Testing Laboratory at Kakinada to support farmers with accurate soil and nutrient analysis. Coromandel fostered sustainable agriculture through collaborations with IFDC and ICAR-NBSS&LUP and instituted the FAI Plant Nutrition Award to promote innovation and research excellence in agriculture.

Specialty Nutrients

Coromandels Specialty Nutrients business continued to be a key driver of its sustainable agriculture mission, delivering a strong performance through innovation, farmer engagement, and channel expansion. The business expanded its treated area significantly, supported by robust market development activities and farmer-centric programs across key regions. Several new products were introduced during the year, including Areca Shakti and Co ee Bliss in the organic segment, Pixibud and Pixigrow in the specialty nutrient segment, and Nanozyme in the Nutribooster category, supporting various critical stages of crop growth. Customer outreach was enhanced through digital engagement and influencer marketing, helping build deeper connections with farmers and boosting product awareness. To meet rising secondary nutrients demand, Bentonite Sulphur production capacity was doubled, ensuring a steady supply and expanded market reach.

Crop Protection

In FY24-25, Coromandels Crop Protection business delivered strong growth across domestic and international markets, while strengthening its operational capabilities. The business expanded production capacity for two existing molecules and commercialized two new herbicide and one fungicide technical molecule. It announced a new state-of-the-art Multi-Product

Plant (MPP) in Gujarat, and advanced its CDMO (Contract Development and Manufacturing Organization) initiatives with global customers. Its plants received certification under Responsible Care standards, reflecting its commitment towards sustainability, safety, health, and environmental excellence across its operations.

On the exports front, the business recorded 9% volume growth, strengthening its presence in Latin America, APAC, and Africa. In the domestic B2C market, it launched ten new products, including three patented ones, raising new product share to 21% in formulations sales.

During the year, Coromandel signed Definitive Agreement to acquire controlling stake in NACL Industries. The proposed acquisition will position Coromandel as one of the leading players in the Indian Crop Protection industry with a wide range of technicals and pan India presence in domestic formulation business. This will also help in expanding Coromandels scale, accelerating its entry into contract manufacturing business, fast-tracking new product commercialization and expanding its product portfolio.

Bioproducts

During the year, the bioproducts business improved manufacturing efficiencies to deliver high-purity Azadirachtin meeting global quality and organic standards. Despite a slowdown in Azadirachtin export markets, the business achieved volume growth. As part of its diversification strategy, it expanded into non-Azadirachtin plant extracts and launched VAM-based bio-fertilizers, which received positive market response. The business also built in-house fermentation and microbial R&D capabilities and plans to launch microbial crop protection products in FY26.

Retail

During the year, the Retail business of the company expanded its footprint by adding 100+ new stores in Andhra, Telangana, Karnataka, and in new markets like Maharashtra and Tamil Nadu. Five new Corocare stores focusing on crop protection marketing were set up. With ~900 centers supported by over 3,000 team members, the Retail centers continued to strengthen companys connect with the farming community.

Retail advanced precision advisory, e-commerce, drone services (over 1 lakh+ acres sprayed), and rural delivery through the new ‘Gromor Sena initiative. It engaged farmers through digital platforms like its YouTube channel with 400k+ subscribers and the quarterly e-bulletin ‘Krishi Shastra. The business also launched new products such as Grovibe, META DAP, Senani, Zithara, and Gromor MAX, further enhancing its offerings. Its farmer-centric approach, including personalized crop recommendations and farmer recognition initiatives has strengthened farmer loyalty. Looking ahead, Coromandel Retail plans to expand into new markets, enhance tech-driven services, and scale drone spraying operations.

Nano products

Focused on promoting sustainable farming, Nano Fertilisers enhances nutrient use efficiency while minimizing environmental residues. During the year, the business commissioned a state-of-the-art Nano Fertiliser plant at Kakinada, with a capacity to produce 1 crore bottles. Its Nano Technology Center in Coimbatore continued to advance innovation in nano applications in agriculture. The business maintained its focus to promote awareness of the product, which has potential to partially replace DAP imports. During the year, it marketed ~2.6 million bottles, registering a market share of 33%.

4. Finance and Credit Ratings

Your Company focused on managing cash efficiently and ensured that it had adequate liquidity and back-up lines of credit. Working capital of the Company improved through the year and Net Cash from Operations for the year stood at Rs. 2,546 Crores.

Your Company has been credit rated by CRISIL Limited (CRISIL) and India Ratings & Research Private Limited (India Ratings & Research). The Companys long-term credit rating by CRISIL has been reafirmed as ‘CRISIL AAA (Stable) and short-term debt rating stands at ‘CRISIL A1+. The Companys long-term credit rating by India Ratings & Research has been reafirmed as ‘IND AAA (Stable) and short-term debt rating stands at ‘IND A1+. This reflects a very strong (highest) degree of safety regarding timely servicing of financial obligations and a vote of confidence reposed in your Companys financials.

5. Dividend

The Board of Directors of the Company at their meeting held on April 30, 2025, has recommended a final dividend of Rs. 6/- per equity share (600%) and a special dividend of Rs. 3/- per share (300%) of face value of Re. 1/- each. The Board had earlier approved for payment of interim Dividend of Rs. 6/- per equity share at its meeting held on January 30, 2025, which was paid to the Members of the Company on February 19, 2025. The total dividend for the financial year ended March 31, 2025 would, accordingly be Rs. 15/- per equity share of Re. 1 each. The said dividend, if approved by the members would absorb a total cash outflow (interim, final and special dividend) of Rs. 442 Crores including Tax Deducted at Source (TDS) for the financial year 2024-25. In compliance with Regulation 43A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Dividend Distribution Policy is available on the Companys website at https://www.coromandel.biz/ investors/policies-2/

6. Consolidated Financial Results

The consolidated financial statements, which are prepared in accordance with the provisions of the Companies Act, 2013 (‘the Act) and the relevant accounting standards, form part of this Annual Report. As required under the provisions of the Act, a statement showing the salient features of the financial statements of the subsidiaries, associates and joint ventures is enclosed as Annexure A to this Report.

The financial statements of the subsidiary companies will be made available to the members of the Company on request and will also be kept for inspection at the Registered Office of the Company.

7. Subsidiary Companies - Performance and Financial Position.

Domestic Subsidiaries

a. Coromandel Chemicals Limited (CCL):

CCL, a wholly owned subsidiary of the Company, earned a total income including exceptional items of Rs. 260.75 crores for the year ended March 31, 2025, and Profit after tax was Rs. 210.68 crores.

During the year 2022-23, the company made a strategic investment in Baobab Mining and Chemicals Corporation SA, Senegal (BMCC) by way of equity and holds 45% stake in it. It made further investment by way of equity in the financial year 2024-25 and now the stake stands at 53.8%.

b. Dare Ventures Limited (DVL):

DVL, a wholly owned subsidiary of the Company, earned a profit of Rs. 0.87 crores for the year ended March 31, 2025.

DVL is a corporate venture capital arm of the Company with focus on leading investments in early to growth stage start-up companies engaged in providing technology led solutions for complex and long-term problems in the agriculture and allied sectors. DVL holds investments in Ecozen Solutions Private Limited (Ecozen), String Bio Private Limited (String Bio) and Flic Farms Private Limited (Flic Farms).

Ecozen develops climate-smart deeptech solutions and core technology stacks to deliver a sustainable future, including motor controls, IoT, and energy storage. With a vision to build a world where cleaner and better ways of living are enabled by biotechnology, String Bio has developed a set of next generation products across different sectors to deliver such solutions.In agriculture, String Bio has developed several bio stimulant products targeting horticulture as well as large acreage crops. Flic Farms is engaged in the business of design and production of compact autonomous robots, equipped with intelligent attachments, to perform a diverse range of agricultural tasks such as seeding, weeding, spraying & planting with precision resulting in higher efficiency & lower chemical usage.

The details of investments made by DVL in AgTech startups Companies during the financial year 2024-25 are as under: Ecozen Solutions Private Limited: DVL further invested Rs. 24 Crores in Ecozen Solutions Private Limited.

c. Coromandel Technology Limited (CTL)

CTL a wholly owned subsidiary of the Company, incurred a loss of Rs. 0.54 crores for the year ended March 31, 2025. CTL increased its equity stake from 51.02% to 58.01% in Dhaksha Unmanned Systems Private Limited (DUMS) in May 2024. DUMS is classified as a subsidiary of the Company with effect from 31 July 2023. Dhaksha is one of the forerunners in the drone space in India, provides a complete range of Unmanned Aerial Systems (UAS) technology solutions for different applications covering agriculture, defence, surveillance and delivery, among others.

d. Dhaksha Unmanned Systems Private Limited (DUMS):

DUMS is a step-down subsidiary of the Company. Dhaksha registered a total income of Rs 47.51 crores comprising mainly of Rs. 35.80 crores from sale of drones and spare parts. The loss before tax for the year is Rs. 23.54 crores as against Rs. 21 Crores in the previous financial year.

e. Coromandel Insurance and Multi Services Limited (CIMSL)

Coromandel Insurance and Multi Services Limited (CIMSL) was incorporated as Coromandel Solutions Limited (CSL) on October 31, 2023 as a wholly owned subsidiary of the Company. The name of the company was changed with effect from August 06, 2024. The Company during the year under review received IRDA approval to act as Corporate Agent (Composite). The net loss for the year is Rs. 0.09 Crores.

Overseas Subsidiaries

f. CFL Mauritius Limited:

CFL Mauritius Limited, a wholly owned subsidiary, incurred a loss of USD 0.04 million (equivalent to Rs. 0.35 crore) during the year ended March 31, 2025. The primary source of income for this subsidiary is dividend income from Foskor (Pty) Ltd. and the subsidiary did not receive any dividend from Foskor during the financial year 2024-25.

g. Coromandel Brasil Limitada (CBL):

CBL, a Limited Liability Partnership, owned 100% by the Company and its subsidiary CFL Mauritius Ltd, is primarily engaged in getting product registrations in Brazil and procuring orders for supplies from India. It earned a profit of Brazilian Reals 0.03 million (equivalent to Rs.0.04 crore) for the year ended March 31, 2025.

h. Coromandel Australia Pty Ltd (CAPL) [Formerly Sabero Australia Pty Ltd]:

CAPL did not have any significant operation during the year ended March 31, 2025. It earned a profit of Australian Dollar 0.00 million (equivalent to Rs. 0.05 crore) for the year ended March 31, 2025.

i. Coromandel America S.A. (formerly Sabero Organics America S.A.) (CAS):

CAS is primarily engaged in getting product registrations in Brazil and procuring orders for supplies from India. It incurred a net profit of Brazilian Reals 0.12 million (equivalent to Rs. 0.18 crore) for the year ended March 31, 2025.

j. Coromandel Agronegocios De Mexico SA de CV (Coromandel Mexico):

Coromandel Mexico is primarily engaged in getting product registrations in Mexico and procuring orders for supplies from India. It earned a net profit of Mexican Peso 0.63 million (equivalent to Rs. 0.28 crore) for the year ended March 31, 2025.

k. Sabero Argentina SA (Sabero Argentina):

Sabero Argentina is primarily engaged in getting product registrations in Argentina and procuring orders for supplies from India. It did not have significant operation during the year ended March 31, 2025.

l. Parry America Inc.:

Parry America Inc. is primarily engaged in the sale of bio-pesticides in America. It made a net loss of USD 0.56 million (equivalent to Rs. 4.77 crore) for the year ended March 31, 2025.

m. Coromandel International (Nigeria) Limited (CINL):

CINL is engaged in getting product registrations in Nigeria and procuring orders for supplies from India. It made a net profit of Naira 28.90 million (equivalent to Rs. 0.16 crore) for the year ended December 31, 2024.

n. Coromandel Mali SASU (CMS):

Coromandel Mali SASU (CMS) was incorporated on February 04, 2020 as a Wholly Owned Subsidiary (WOS) of the Company for the purpose of obtaining registration for marketing of agrochemicals. CMS is registered with Ministry in Charge of Statistics, Republic of Mali. It did not have any business operations during the financial year 2024-25.

o. Coromandel Vietnam Company Limited

Coromandel Vietnam Company Limited was incorporated on October 16, 2024 as a Wholly Owned Subsidiary of the Company. Coromandel Vietnam Company Limited did not have any business operations during the financial year 2024-25.

p. Baobab Mining and Chemicals Corporation SA, Senegal (BMCC)

BMCC is a registered corporate entity in Dakar, Republic of Senegal (West Africa) and is engaged in the business of mining, production and sale of Rock Phosphate, one of the key raw materials used in manufacturing of phosphoric acid, which in turn is used in manufacturing of complex fertilizers.

In FY 2022-23, your Company made a strategic investment in BMCC through its wholly owned subsidiary, Coromandel Chemicals Ltd. (CCL) to secure supply of Rock Phosphate, on a long-term and sustainable basis. In the FY 2024-25, Your company through CCL made further investment by acquisition of equity and now CCL holds 53.8%, thereby making BMCC a subsidiary of your Company. During FY 2024-25, BMCC has undertaken several operational improvement initiatives and strengthened its team structure. The Companys share of loss for the year ended March 31, 2025 amounted to Rs. 54.55 Crores.

Associate Company

Coromandel Crop Protection Philippines Inc. (CCPPI)

CCPPI, an associate company based in Philippines, is engaged in obtaining product registrations in Philippines enabling supplies from India. The total income earned during the year was Rs. 0.52 crore and the net loss was Rs. 0.85 crore.

Strategic Investment(s)

Brief details of the performance of the Strategic Investment companies are given below:

Tunisian Indian Fertilisers S.A., Tunisia (TIFERT):

TIFERT, a company based in Tunisia, manufactures phosphoric acid which is a key raw material for operating Phosphatic Fertiliser plants. Your Companys strategic investment in TIFERT (15% equity) is aimed at securing supply of phosphoric acid for the Companys operations at Kakinada and Visakhapatnam. During the year, TIFERT operations were impacted by technical issues. Indian partners, Coromandel and GSFC, continue to provide necessary technical support to TIFERT to improve the plant performance.

Foskor (Pty) Limited, South Africa (Foskor):

The Company, along with CFL Mauritius Limited, holds 14% equity in Foskor. Foskor supplies high-quality phosphoric acid, which is used for phosphatic fertiliser manufacturing at Kakinada and Ennore plants of your company.

8. Risk Management Policy

The Company has constituted a Risk Management Committee, as per the details set out in the Corporate Governance Report. The Company has formulated a Risk Management Policy to ensure risks associated with the business operations are identified and risk mitigation plans put in place. Details of the key risk associated with the business are given in the Management Discussion and Analysis Report.

9. Internal Financial Control Systems and their adequacy

The Company has adequate internal controls consistent with the nature of business and size of the operations, to effectively provide for safety of its assets, reliability of financial transactions with adequate checks and balances, adherence to applicable statutes, accounting policies, approval procedures and to ensure optimum use of available resources. These systems are reviewed and improved on a regular basis. It has a comprehensive budgetary control system to monitor revenue and expenditure against approved budget on an ongoing basis.

The Company has its own corporate internal audit function to monitor and assess the adequacy and effectiveness of the Internal Controls and System across all key processes covering various locations. Deviations are reviewed periodically, and due compliance ensured. Summary of Significant Audit Observations along with recommendations and its implementations are reviewed by the Audit Committee and concerns, if any, are reported to the Board

10. Related Party Transactions

All related party transactions entered during FY 2024-25 were on arms length basis and in the ordinary course of business and were reviewed and approved by the Audit Committee. Prior omnibus approval of the Audit Committee was obtained for the transactions which are foreseen and are repetitive in nature and entered in the ordinary course of business and on an arms length basis. A statement giving details of all related party transactions entered pursuant to the omnibus approval so granted is placed before the Audit Committee on a quarterly basis for its review.

During the year under review, the Company there were no contracts or arrangements with related parties or material related party transactions were entered into pursuant to Section 188(1) of the Companies Act, 2013 read with the relevant rule which may have a potential conflict with the interest of the Company at large. The disclosure of related party transactions as required under Section 134(3)(h) of the Companies Act, 2013 read with Rule 8(2) of the Companies (Accounts) Rules, 2014 in

Form AOC-2 is Annexed as Annexure B.

In terms of Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company submits details of related party transactions on a consolidated basis as per the specified format to the stock exchanges on a half-yearly basis. The details of the transactions with related parties are provided in the accompanying Financial Statements.

Related party transactions as required under the Indian Accounting Standards are disclosed in Notes to the financial statements of the Company for the financial year ended March 31, 2025. The Policy on Related Party Transaction is available on the Companys website at https://www.coromandel.biz/ investors/policies-2/

None of the Directors had any pecuniary relationship or transactions with the Company except the payments made to them in the form of remuneration, sitting fee, commission and reimbursement of expenses, if any.

11. Auditors

i. Statutory Auditors

M/s. S.R. Batliboi & Associates LLP (Reg. No. FRN 101049W/ E300004) were appointed as the Statutory Auditors of the Company to hold office from the conclusion of 59th Annual General Meeting until the conclusion of the 64th Annual General Meeting by the Members of the Company. The report of the Statutory Auditors on the financial statements of the Company for the financial year 2024-25 forms part of this Integrated Annual Report. As required under Regulation 33 of the Listing Regulations, the Auditors have confirmed that they hold a valid certificate issued by the Peer Review Board of the Institute of Chartered Accountants of India.

The Auditors Report does not contain any qualification, reservation or adverse remark. During the year under review, the Auditors did not report any matter under Section 143(12) of the Companies Act, 2013. Therefore, no detail is required to be disclosed by the Board, under Section 134(3)(ca) of the Companies Act, 2013.

ii. Secretarial Auditors

Pursuant to the provisions of Section 204 of the Act and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, as amended, the Company had appointed M/s. R. Sridharan & Associates, Practicing Company Secretaries to undertake the Companys secretarial audit for financial year 2024-25. Therefore, no detail is required to be disclosed by the Board under Section 134(3)(ca) of the Companies Act, 2013. The report of the Secretarial Auditor in Form MR-3 for the financial year ended March 31, 2025 is attached to this Report as Annexure C. The Secretarial Audit Report does not contain any qualifications, reservations, adverse remarks or disclaimers. Based on the recommendation of the Board at its meeting held on April 30, 2025, M/s. Sridharan & Sridharan Associates, Company Secretaries, is proposed to be appointed as the Secretarial Auditors of the Company to hold office for a term of five consecutive years from the conclusion of ensuing 63rd Annual General Meeting (‘AGM) till the conclusion of 68th AGM of the Company to be held in the Year 2030, subject to the approval of shareholders as per the SEBI, (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Section 204 of the Act and Rules thereunder.

None of the subsidiaries of the Company is a material subsidiary during the financial year 2024-2025. Hence, the requirement to annex the Secretarial Audit Report of the material subsidiary along with this report in terms of Regulation 24A of the Listing Regulations is not applicable. iii. Cost Auditors

Pursuant to Section 148 of the Act read with the Companies (Cost Records and Audit) Rules, 2014 and amendments thereof, the Company is required to maintain cost accounting records in respect of certain specified products and accordingly such accounts and records are made and maintained in the prescribed manner. The cost accounting records maintained by the Company are required to be audited and accordingly M/s. Narasimha Murthy & Co., and Mrs. Jyothi Satish were appointed as Cost Auditors for the financial year 2025-26. On the recommendation of the Audit Committee, the Board has re-appointed M/s. Narasimha Murthy & Co., Cost Accountants and Mrs. Jyothi Satish, Cost Accountant as Cost Auditors for auditing the cost records of the Company for the financial year 2025-26. The Act mandates that the remuneration payable to the Cost Auditor is ratified by the shareholders. Accordingly, a resolution seeking ratification of the shareholders for the remuneration payable to the Cost Auditors for the financial year 2025-26 is included in the Notice convening the 63rd Annual General Meeting. During the year, the Company filed the Cost Audit Report for the financial year 2023-24 with the Ministry of Corporate Affairs.

12. Board, Committees of the Board and other information

a. Directors

Your Company is managed and governed by a Board comprising an optimum combination of Executive and Non-Executive Directors. The Board of Directors comprised of Eleven (11) Directors, consisting of one Executive Chairman, one Managing Director and Chief Executive Officer, one(1) Executive Director, two (2) Whole-time Directors and Six (6) Non-Executive Directors Independent Directors, including One (1) Woman Director Independent Director. The Directors possess requisite qualifications and experience in general corporate management, strategy, finance, engineering, information technology and other allied fields which enable them to contribute effectively to the Company in their capacity as Directors of the Company.

During the year, Mr. A. Vellayan, Chairman and M M Venkatachalam, Director retired from Directorships w.e.f April 25, 2024. The Board placed on record its appreciation for their significant contribution made during their tenure.

During the year, Mr. Arun Alagappan (DIN 00291361) was redesignated as Executive Chairman effective April 26, 2024. Mr. Arunachalam Vellayan (DIN 08011680)and Mr. Narayanan Vellayan (DIN 07774406) were appointed as Directors effective from May 6, 2024. Mr. Durgashankar Subramaniam (DIN 00044713) was appointed as Director effective August 19, 2024 , for a term of five years and the shareholders have approved the same vide postal ballot. Mr. Sankarasubramanian was re-designated as Managing Director and Chief Executive Officer effective August 7, 2024.

Further, Mr A Vellayan was appointed as Chairman Emeritus effective April 26, 2024 in recognition of his contributions to the Company, guidance to the senior management and the company over the past several years as his tremendous experience the company would continue to benefit from his rich experience, valuable knowledge, and guidance from time to time.

In accordance with Article 17.29 of the Companys Articles of Association, read with Section 152 of the Act, Mr. Arun Alagappan, Executive Chairman (DIN 00291361) retires by rotation at the ensuing Annual General Meeting and, being eligible, offers himself for re-election.

b. Board Meetings

The annual calendar of the board meetings is prepared and circulated to the Directors in advance. During the financial year 2024-25, seven (7) Board Meetings were held, the details of which are given in the Corporate Governance Report.

c. Independent Directors and their declaration of Independence

In terms of Section 149 of the Companies Act, 2013, Mr. Sudarshan Venu, Dr. Deepali Pant Joshi, Mr. Adnan Ahmad, Mr. Aditya Himatsingka, Mr Suresh Subramanian and Mr. Durgashankar Subramaniam are Independent Directors of the Company. All the Independent Directors of the Company have furnished necessary declaration in terms of Section 149(6) of the Companies Act, 2013 and Regulation 16(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and are independent of the Management. In terms of Regulation 25(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they have confirmed that they are not aware of any circumstance or situation which exist or may be reasonably anticipated, that could impair or impact their ability to discharge their duties with an objective independent judgement and without any external influence. The Board of Directors of the Company has taken on record the declaration and confirmation submitted by the Independent Directors after undertaking due assessment of the veracity of the same. The Board is of the opinion that all Independent Directors of the Company uphold highest standards of integrity and possess requisite expertise and experience required to meet their duties as Independent Directors.

The Independent Directors of the Company have confirmed that they have enrolled themselves in the Independent Directors Databank maintained with the Indian Institute of Corporate Affairs (‘IICA) in terms of Section 150 of the Act read with Rule 6 of the Companies (Appointment & Qualification of Directors) Rules, 2014.

d. Familiarization Programmes for Independent Directors

The Independent Directors of the Company are eminent professionals with several decades of experience in banking and financial services, technology, finance, governance and management areas, and fully conversant and familiar with the business of the Company.

The Company has an ongoing familiarization programme for all Independent Directors with regard to their roles, duties, rights, responsibilities in the Company, nature of the industry in which the Company operates, the business model of the Company, etc. The Independent Directors, on their appointment, are made familiar about the Companys operations and businesses. Interaction with the senior leadership team (Business Heads and key executives) of the Company is also facilitated. Detailed presentations on the business of each of the Division are made to the Directors from time to time. Meetings with the Executive Chairman and the Whole Time Directors/ Executive Directors are facilitated for the new appointee to familiarise him/ her about the Company, its businesses and the practices and policies of the Group.

Further, periodic emails are sent to all the Directors covering events that may have an impact on the business of the Company and/ or the agriculture sector in general and,fertiliser and crop protection industries, in particular. The details of the familiarization programme are also disclosed on the Companys website.

e. Remuneration Policy48

On the recommendation of the Nomination and Remuneration Committee, the Board has framed a policy for selection and appointment of Directors, Senior Management and their remuneration. Salient features of the Remuneration Policy are set out in the Corporate Governance Report. The Remuneration Policy is available on the Companys website at https://www.coromandel.biz/wp-content/uploads/2025/02/5-RemunerationPolicy.pdf

f. Evaluation of the Boards performance, its Committees and Directors

The Board has carried out the annual evaluation of its own performance and that of its committees and individual Directors for the year pursuant to the provisions of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The performance of the Board and individual Directors was evaluated by the Board after seeking inputs from all the Directors. The criteria for performance evaluation of the Board included aspects such as Board composition and structure, effectiveness of Board processes, contribution in the long-term strategic planning, etc. The performance of the Committees was evaluated by the Board after seeking inputs from the Committee Members. The Independent Directors evaluated the performance of Non-Independent Directors and performance of the Board as a whole including the Chairman of the Board taking into account the views of Executive Directors and Non-Executive Directors. The manner in which the evaluation has been carried out is explained in the Annual Report disclosures under Regulation 34 and Schedule V of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which forms part of this report (please refer page no. 202)

g. Audit Committee

As on March 31, 2025, the Audit Committee comprises of Mrs. Deepali Pant Joshi, Chairperson, Mr. Aditya Himatsingka, Mr. Suresh Subramanian and Mr. Sankarasubramanian, Members. Mr. Arun Alagappan ceased to be a Member with effect from August 7, 2024 and Mr. Sankarasubramanian was appointed as Member with effect from August 7, 2024. During the year, seven (7) meetings of the Audit Committee were held, the details of which are provided in the Corporate Governance Report. All the recommendations made by the Audit Committee were accepted by the Board.

h. Directors Responsibility Statement

Accordingly, pursuant to Sections 134(3)(c) and 134(5) of the Act, the Directors, to the best of their knowledge and ability, confirm that for the year ended March 31, 2025:

a) In the preparation of the annual accounts, the applicable accounting standards have been followed and that there are no material departures;

b) They have selected such accounting policies and applied them consistently and made judgements and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period;

c) They have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

d) They have prepared the annual accounts on a going concern basis;

e) They have laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and are operating effectively; and

f) They have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively.

13. Key Managerial Personnel

Pursuant to the provisions of Section 203 of the Act read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, Mr. Arun Alagappan, Executive Chairman, Mr. Sankarasubramanian S., Managing Director and Chief Executive Officer, Dr. Raghuram Devarakonda, Executive Director – CPC, Bio and Retail Business, Mr. Arunachalam Vellayan, Whole-time Director - Strategy and Planning, Mr. Narayanan Vellayan, Whole-time Director – Strategic Sourcing, Mrs. Jayashree Satagopan, President – Corporate

& Chief Financial Officer and Mr. B. Shanmugasundaram, Senior Associate Vice President– Company Secretary and Compliance Officer are the Key Managerial Personnel of the Company.

14. Policy on prevention, prohibition and redressal of Sexual Harassment at workplace

The Company has put in place the Prevention of Sexual Harassment Policy (POSH) in line with the requirements of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. An Internal Compliance Committee (ICC) has been constituted in compliance with the requirements of said Act to redress complaints received regarding sexual harassment. All employees are covered under this Policy. Employees at all levels are being sensitized about the Policy and the remedies available thereunder. During the financial year 2024-25, 3 complaints were received and disposed by the ICC during the year under review.

15. Employee Stock Option Plans

Employee Stock Option Plan 2016

The Employee Stock Option Plan 2016 (ESOP 2016), as approved by the Shareholders through Postal Ballot on January 11,2017, was operational during the year. The Board/ Nomination and Remuneration Committee has been authorised to issue to the employees such number of Options under ESOP 2016 as would be exercisable into not exceeding 1,45,81,000 fully paid- up equity shares of Re. 1/- each in the Company. Pursuant thereto, the Nomination and Remuneration Committee has formulated detailed terms and conditions of the ESOP 2016. Upon implementation of ESOP 2016 the earlier ESOP Scheme 2007 ceased to exist. There were no vested Options outstanding at the end of the financial year. There will be no further grants issued under the ESOP Scheme 2007. Further, the Nomination and Remuneration Committee is empowered to determine the eligible subsidiary companies, whether existing or future, whose employees will be entitled to stock options under ESOP 2016. Options granted under ESOP

2016 would vest on or after 1 (one) year from the date of grant but not later than 4 (four) years from the date of grant of such Options or any other terms as decided by the Nomination and Remuneration Committee. The Company has granted options to the employees during the year under the ESOP 2016. The number of vested Options outstanding as on March 31, 2025 are 5,49,920. The total number of options allotted and listed upto March 31, 2025 is 1,93,370. The disclosure required to be made under Regulation 14 of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 is available on the website of the Company at https://www.coromandel.biz/ investors/annual-general-meeting-postal-ballot/

Employee Stock Option Plan 2023

The Employee Stock Option Plan 2023 (ESOP 2023), as approved by the Shareholders at the Annual General Meeting held on July 27, 2023, was operational during the year. The Board / Nomination and Remuneration Committee has been authorised to issue to the employees such number of Options under ESOP 2023 as would be exercisable into not exceeding 58,80,900 fully paid- up equity shares of Re. 1/- each in the Company. Pursuant thereto, the Nomination and Remuneration Committee has formulated detailed terms and conditions of the ESOP 2023 scheme.

The details required under Rule 12 (9) of Companies (Share Capital and Debentures) Rules, 2014 and the disclosure required to be made under Regulation 14 of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 is available on the website of the Company at https://www. coromandel.biz/investors/annual-general-meeting-postal-ballot/

16. Vigil Mechanism/ Whistle Blower Policy

Pursuant to Sections 177(9) and (10) of the Companies Act, 2013 and Regulation 22 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has a Vigil Mechanism through a Whistle Blower Policy. The details about the whistle blower policy are provided in the Annual Report Disclosures under Regulation 34 read with Schedule V of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The Vigil Mechanism is hosted at https:// www.coromandel.biz/investors/policies-2/

17. Corporate Governance

The Company is committed to maintain the highest standards of Corporate Governance. As stipulated under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Report on Corporate Governance is appended asAnnexure D to this Report. The requisite certificate from M/s. R Sridharan

& Associates, Company Secretaries confirming compliance with the conditions of Corporate Governance by the Company is also attached to the Report on Corporate Governance.

18. Management Discussion & Analysis

The Management Discussion & Analysis, as required in terms of Regulation 34(2)(e) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, forms part of this Integrated Annual Report.

19. Business Responsibility and Sustainability Report

Pursuant to Regulation 34(2)(f) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has prepared the Business Responsibility and Sustainability Report in line with the business principles as provided in the Business Responsibility Policy adopted by the Company. The Business Responsibility and Sustainability Report is enclosed as Annexure E to this Report and the same is also available on the website of the Company.

20. Corporate Social Responsibility

The Murugappa group is known for its tradition of philanthropy and community service. The groups philosophy is to reach out to the community by establishing service-oriented philanthropic institutions in the field of education and healthcare as the core focus areas. The Company upholds the groups tradition by earmarking a part of its income for carrying out its social responsibilities.

The Company has been carrying out Corporate Social Responsibility (CSR) activities for many years now even before it was mandated under the Act. The Company has put in place a CSR policy, which is available on the website of the Company at https://www.coromandel.biz/sustainability/

As per the provisions of Section 135 the Act and the Rules made thereunder, the Company is required to spend Rs. 4,564 lakhs for the financial year 2024-25 i.e. 2% of the average net profits of the Company made during the three immediately preceding financial years. The Company, however, spent an amount of Rs. 3,237 Lakhs towards CSR activities during the financial year 2024-25. The unspent amount of Rs. 1,327 Lakhs on the ongoing projects has been transferred in April 29, 2025 to a separate bank account titled Coromandel International Limited - Unspent CSR Account -2024-25 and shall be spent within the time limits and in such manner as specified in the Act and the Rules made thereunder.

Details of the composition of the Corporate Social Responsibility & Sustainability Committee and the CSR Projects undertaken during the year are given in the Annual Report on CSR Activities, which is appended as Annexure F to this Report.

21. Environment, Health and Safety (EHS)

At our Company, EHS is given the highest priority. We are committed to operating all our facilities safely, efficiently, and in an environmentally responsible manner. To uphold this commitment, we have implemented robust processes and established clear safety performance indicators to systematically track and improve our EHS performance.

We believe that a proactive safety culture is the key to achieving excellence in EHS. Employees are actively encouraged to identify and report unsafe acts, unsafe conditions, and near-miss incidents. These reports are monitored regularly, and appropriate corrective and preventive actions are taken in a timely manner. Through continuous engagement and accountability at all levels, we strive to create a safe, healthy, and sustainable workplace for everyone.

Nutrient Business

During the year 2024-25, there were 1 reportable, and 6 recordable incidents across Nutrient operations. Total Recordable Injury Rate (TRIR) stood at 0.37 at the end of the year.

Kakinada site has surpassed 14 million Safe Manhours during the year.

Safety Culture Survey was conducted at Vizag, Kakinada and Ennore sites by M/s JMJ

Nutrient operations have received the following recognitions during year:

• Best Practices Award at Sanrakshan 2.0 – Plastic Sustainability Awards 2025 for achieving 100% recycling of the targeted Plastic waste and fulfilling all statutory requirements as per the PWM rules under Chemicals Category.

• Vizag unit was honoured with British Safety Councils International Safety Award with distinction.

• Kakinada and Vizag units have received Safety Excellence Award under Gold and Silver Category respectively from CII.

• Kakinada unit has received "Best Safety Practices" Award from DOF by Govt. of Andhra Pradesh

• Kakinada unit was adjudged with "Kalinga Environment Excellence Award in the Five-star category"

• Vizag unit has secured 1st place in Special Campaign 3.0 Institutionalizing Swachata by VPA

• Vizag unit has received AP State Sustainability Leadership Award

• Ranipet unit has received Environment award from FAI.

• Kakinada unit received "Managing Director Award for the Best Performing Unit in EHS

• SSP units at Ennore & Hospet has won Managing Director awards for EHS performance

Following safety initiatives were taken during the year:

• Comprehensive audits on ammonia systems at Fertilizer sites by subject matter experts.

• Specialized training in Process Hazard Analysis (HAZOPs), Process Safety Management System, and Root Cause Analysis.

• Quantitative Risk Assessment studies for Vizag & Kakinada sites by M/s DNV

• HAZOP by M/s CLRI for Ammonia ship unloading and storage and handling at Ennore site

• Assets Integrity audit by M/s TATA Projects at Vizag & Kakinada sites

• Sulphur facility audit by external experts at Vizag site

• Regular mock drills at all the sites to test emergency responses.

Under ESG front, the following have been achieved:

• Use of non-conventional water to the extent of 32% using desalination plant.

• Sustainable livelihood development project through water conservation and management at Udaipur. This is aimed at harvesting 1 lac KL of rainwater.

• SSP sites have used 1524 MT of bio-briquettes, reducing Coal consumption by 8.3 %

• Three buildings certified as Green Buildings at Vizag site

• Tree plantation (50000 nos) under Green Belt 2.0 program initiated at Vizag site

• Roof Top Solar installed at Kota (21 KW), Vizag (16 KW) & Kakinada (50 KW)

• Life cycle assessment for 2 products (Nano DAP from Kakinada & 20:20 from Vizag)

Enhancing Emergency Preparedness

To strengthen our emergency preparedness, continuous emphasis has been placed on capacity-building programs for the Emergency Response Team (ERT). Regular training sessions have been conducted in collaboration with both internal and external agencies, including the National Disaster Response Force (NDRF) and local fire department teams. These programs are designed to ensure that our personnel are well-equipped to respond effectively to any emergency.

Crop Protection Chemicals Business (CPC)

During the year 2024-25, CPC business has continued its sustained efforts towards safety culture enhancement, which has helped in achieving zero LTI. Total Recordable Injury Rate (TRIR) stood at 0.14 at the end FY25, which is the lowest in the last 5 years.

Accreditation to ‘Responsible Care Management System- RC was achieved during the year. CPC business has received RC logo from Indian Chemical Council.

During March25, Ankleshwar site has undergone Occupational Health and Safety Best Practice Audit from British Safety Council and achieved 4 Star rating.

With the vision of Technology-in Safety, various initiatives were taken across CPC sites to improve behavioural safety, that includes the following:

• AI based Video analytics

• Group Safety training KIOSK

• Camera for supervision of Height work job

• Forklift safety with use of sensor

• QR code-based visitor safety induction training

• Lone worker monitoring in high-risk area

• Safety Beacon installation in critical operations

Theme based safety campaigns were observed across all CPC sites throughout the year that includes Asset Integrity, Chemical Handling Safety, Job Safety Assessment, Process Safety Management and Portable Power tools Safety.

Coromandel Safety Week was celebrated across all business sites with the theme of "Safety-Our way of Life". The campaign has set safety as a value for business and made everyone demonstrate safety as an integral part of all activities.

Safety leading indicators such as Safety Trainings, Safety Inspections, Toolbox Talks and Plant Walk through were tracked in a structured manner, which has helped to achieve Zero LTI and lowest TRIR 0.14.

During the year 2024-25, the CPC plants achieved the following safety accolades:

Sarigam & Ankleshwar Plants received the following awards: Best EHS initiatives Award from Greentech Foundation and Best EHS initiatives from INVENTICON BUSINESS INTELLIGENCE

Dahej Plant received the following awards:

Suraksha Purashkar (Bronze Trophy & Certificate) from National Safety Council, OSH Award under the category of "Diversity & inclusion" in Safety, The "Great Indian Sustainable Initiative to GHG Emissions Reduction" award, FGI Excellence award for under the "Industrial Safety & Compliance", Commitment to Environment Excellence from INVENTICON BUSINESS INTELLIGENCE and EHS initiatives Award from Greentech Foundation.

Focusing on process safety, ‘Safety Barrier Assessment was conducted for Sarigam site covering all products aided by a subject matter expert consultant. Validation of implementation of all audits & assessments were completed with the help of external consultant. Industrial Hygiene Qualitative Study was completed for all 3 technical sites to improve the workplace conditions. Expert toxicologist was engaged in the development of SOPs on chemical exposure emergency response for 35 chemicals.

Various employee engagement and safety awareness were conducted including Road Safety Week, National Safety Week, National Fire Service Week, World Environment Day programs across CPC plants.

Green belt to the extent of 33% was achieved across technical sites.

22. Other disclosures

a. Share Capital

The paid-up equity share capital of the Company as on March 31, 2025 was Rs.29.46 crore. During the year, the Company has allotted 1,93,370 equity shares of Re.1 each under ESOP 2016.

b. Material Subsidiary Policy

The Company has adopted a policy for determining material subsidiary, in line with the requirements of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the same is available on the website of the Company at https://www.coromandel.biz/ investors/policies-2/. However, the Company does not have any material subsidiary.

c. Annual Return

In accordance with Section 92(3) read with Section 134(3)(a) of the Companies Act, 2013, the Annual Return as on March 31, 2025, is available on the website of the Company at https://www.coromandel.biz/investors/ annual-general-meeting-postal-ballot/

d. Conservation of energy, technology absorption, foreign exchange earnings and outgo.

The particulars of conservation of energy, technology absorption, foreign exchange earnings and outgo, as prescribed under sub-section (3)(m) of Section 134 of the Companies Act, 2013, read with Companies (Accounts) Rules, 2014, are enclosed as Annexure G to this Report and form part thereof.

e. Particulars of Employees and Remuneration

The disclosure with respect to remuneration as required under Section 197 of the Companies Act, 2013 read with rule 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is appended as Annexure H to this report.

The statement containing names of top ten employees in terms of remuneration drawn and the particulars of employees as required under Section 197(12) of the Companies Act, 2013 read with Rule 5(2) and 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, is provided in a separate annexure forming part of this report.

However, the annual report is being sent to the Members excluding the aforesaid annexure. In terms of Section 136 of the Act, the said annexure is open for inspection at the Registered Office and any Member interested in obtaining a copy of the same may write to the Company Secretary.

Pursuant to Section 197 (14) of the Companies Act, 2013, the Whole-time Directors of the Company did not receive any remuneration or commission from any of its subsidiaries.

f. Particulars of Loans, Guarantees and Investments

Details of loans and guarantees given and investments made under Section 186 of the Companies Act, 2013 are given in the Notes to the Financial Statements.

g. Public Deposits

The Company has not accepted any deposits from the public falling within the ambit of Section 73 of the Companies Act, 2013 read with Companies (Acceptance of Deposits) Rules, 2014 and no amount of principal or interest was outstanding as on the Balance Sheet date.

h. Compliance of Secretarial Standards

The Company has complied with the applicable Secretarial Standards issued by The Institute of Company Secretaries of India and approved by Ministry of Corporate Affairs.

i. Reporting of Frauds

There was no instance of fraud during the year under review, which required the Auditors to report to the Audit Committee and / or Board under Section 143(12) of the Companies Act, 2013 and the rules made there under. Hence, no detail is required to be disclosed by the Board under Section 134(3)(ca) of the Companies Act, 2013

j. Change in the Nature of Business

There was no change in the nature of business of the Company during the financial year.

k. Material changes and commitments

There were no material changes and commitments affecting the financial position of the Company between the end of the financial year and the date of this Report. l. The criteria for evaluation of performance of Independent Directors and the Board of Directors pursuant to Section 178 of the Companies Act, 2013 and Schedule IV of the Companies Act, 2013 the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed as Annexure I. m. Names of Companies which have become or Ceased to be Companys Subsidiaries, Joint Ventures or Associate Companies during the year: Baobob Mining and Chemicals Corporation SA, Senegal (BMCC):

Your company through Coromandel Chemicals Limited, a Wholly owned subsidiary of the Company made further investment by acquisition of equity and CCL holds 53.8%, thereby making BMCC a subsidiary of your Company.

Yanmar Coromandel Agrisolutions Private Limited (YCAS):

YCAS ceased to be a Joint Venture effective September 27, 2024.

23. Declaration/Afirmations

During the year under review a. there are no significant material orders passed by the Regulators or Courts which would impact the going concern status of the Company and its future operations. b. there are no applications made or any proceedings pending under the Insolvency and Bankruptcy Code, 2016. c. the Company has not made any one-time settlement with any Bank or Financial Institution as such disclosure or reporting requirements in respect of the details of difference between amount of the valuation done at the time of one-time settlement and the valuation done while taking loan from the Banks or Financial Institutions is not required.

24. Banks and financial institutions

Your Company is prompt in making the payment of interest and repayment of loans to the financial institutions/ banks. Banks and Financial Institutions continue their unstinted support in all aspects and the Board had placed on record its appreciation for the same.

25. Acknowledgement

Your directors wish to express their grateful appreciation for the valuable support and co-operation received from bankers, business associates, lenders, financial institutions, shareholders, various departments of the Government of India, as well as the State Governments, the farming community and all our other stakeholders.

The Directors acknowledge and would like to place on record the commitment and dedication on the part of the employees of your Company for their continued efforts in achieving good results.

On behalf of the Board of Directors

	Arun Alagappan
Place: Chennai	Chairman
Date : April 30, 2025	DIN. 00291361